BIZD: Private Credit Is Still In Trouble Source link
Business
Stock futures sink, oil spikes as Navy looks to block Iran’s exports and break its grip on Hormuz
After a week when ceasefire hopes lifted sentiment and stock prices on Wall Street, the U.S. war on Iran could...
Stock market today: Dow, S&P 500, Nasdaq futures fall as the US and Iran fail to agree to peace, US blockades Hormuz
US stock futures slid sharply Sunday evening after President Donald Trump said the US would move to block all...
Northrop Grumman launches Cygnus XL cargo mission to space station
Northrop Grumman launches Cygnus XL cargo mission to space station Source link
Some of Swalwell’s fellow Democrats urge him to quit Congress amid sexual assault allegations
Some of Swalwell’s fellow Democrats urge him to quit Congress amid sexual assault allegations Source...
Iran’s crumbling economy is the regime’s greatest weakness as authorities worry about making payroll
The Iranian economy was already in shambles before the U.S. and Israel launched their war on the Islamic...
Biotech firm takes the battle to metastasis
PREVENTIVE TECH. Arnab Roy Chowdhury, founder of Mestastop Bengaluru-based biotech startup Mestastop is...
The Artificial Intelligence (AI) Stock Market Is Sending Mixed Signals Right Now. Here’s How I’m Reading Them.
The first quarter of 2026 has been rough on artificial intelligence (AI) stocks ... or has it? On the one hand,...
Plastic concerns – The HinduBusinessLine
India’s appetite for petrochemicals has been rapidly growing | Photo Credit: William_Potter The Iran war has...
Trump says it will take a little while for US to blockade the Strait of Hormuz
Trump says it will take a little while for US to blockade the Strait of Hormuz Source link
This TikTok sensation sold her startup for $2 billion. Now Pepsi is letting ‘Poppi be Poppi’
Allison Ellsworth admits she’s not the typical founder story. She was, by her own telling, “a solid C student,”...
GSK sees blockbuster potential in targeted cancer therapy after promising early data
GSK sees blockbuster potential in targeted cancer therapy after promising early data Source link
























